Rotatable Bed Reactor with Porous Matrix for Platelet Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for large-scale platelet production from megakaryocytes face challenges in scalability, efficiency, and cost-effectiveness, with existing bioreactors requiring large volumes of materials and consumables, and struggling to achieve high platelet yields while maintaining platelet quality.
Innovation Solution
A rotatable bed reactor system using a porous material with a gradient in pore density, coated with von Willebrand factor, allows megakaryocytes to attach and elongate, producing platelets efficiently within a short time frame, with the ability to process high volumes of cells at high concentrations using a minimal amount of culture medium.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If existing bioreactors use large volumes of materials and consumables to process megakaryocytes, then platelet production capacity increases, but device complexity and cost increase
Solution Approach 1:
The patent employs a porous matrix as the core component of the bioreactor, which provides a large surface area for megakaryocyte attachment and platelet formation within a compact volume. The porous structure enables high cell density processing without requiring large device volumes or excessive consumables, thus maintaining high productivity while reducing device complexity
Solution Approach 2:
The patent optimizes physical parameters including pore size distribution, porosity percentage, and flow rate through the porous matrix to maximize platelet production efficiency. By carefully controlling these parameters, the system achieves high productivity with minimal material volumes and simplified device architecture
2Productivity
If existing bioreactors use large volumes of culture medium, then cell processing capacity increases, but loss of substance and cost increase
Solution Approach 1:
The porous matrix concentrates cells within its structure, allowing high cell density processing in a minimal volume of culture medium. The matrix acts as a cell retention structure while permitting nutrient diffusion and waste removal, enabling high productivity with dramatically reduced medium consumption compared to conventional bioreactors
Solution Approach 2:
The patent uses a porous matrix that can be replicated and reused multiple times for platelet production. This reusable component eliminates the need for disposable large-volume culture systems, reducing both substance loss and operational costs while maintaining high cell processing capacity
3Productivity
If megakaryocytes are processed at high concentration, then platelet yield increases, but device complexity increases to maintain quality
Solution Approach 1:
The porous matrix provides localized optimal conditions for megakaryocyte attachment and platelet formation throughout its structure. The uniform distribution of pores creates consistent microenvironments that maintain platelet quality even at high cell concentrations, eliminating the need for complex zoned structures or multiple processing chambers
Solution Approach 2:
The porous structure naturally facilitates cell distribution and interaction at high densities while maintaining adequate space for platelet release. The interconnected pore network prevents cell clumping and ensures uniform processing, enabling high platelet yield without requiring complex flow control mechanisms or additional device components
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The system enables rapid platelet production (up to 12 hours) with increased yields and improved platelet quality, overcoming previous limitations in scalability and resource usage, allowing for industrial-scale production.
Implementation Method 1
allows megakaryocytes to attach and elongate
Implementation Method 2
coated with von Willebrand factor
Implementation Method 3
A rotatable bed reactor system using a porous material
Data Source
AI summary
A method and device for large-scale platelet production in vitro are provided. The method uses a platelet production device comprising a rotatable bed reactor configured to contain a porous material for producing platelet from megakaryocytes at large scale.